Jazz Pharmaceuticals (JAZZ) Gross Profit (QoQ) (2010 - 2026)

Jazz Pharmaceuticals (JAZZ) Gross Profit (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,071.81 Bn -
2 Nanobiotix 1,925.70 Bn 1,925.64 Bn -
3 Akari Therapeutics 1,062.88 Bn 1,062.88 Bn -
4 BeOne Medicines 469.09 Bn 464.29 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.09 Bn 115.84 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.32 Bn 61.57 Bn 3.31 Bn
7 Belite Bio 63.36 Bn 63.36 Bn -
8 Argenx Se 55.90 Bn 50.71 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.69 Bn 34.68 Bn 959.66 Mn
10 Jazz Pharmaceuticals 15.79 Bn 13.94 Bn 934.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.49%
Dec 31, 2025 4.73%
Sep 30, 2025 7.29%
Jun 30, 2025 17.18%
Mar 31, 2025 -17.33%
Dec 31, 2024 1.71%
Sep 30, 2024 3.22%
Jun 30, 2024 13.32%
Mar 31, 2024 -10.85%
Dec 31, 2023 3.99%
Sep 30, 2023 1.19%
Jun 30, 2023 12.51%
Mar 31, 2023 -5.04%
Dec 31, 2022 -0.28%
Sep 30, 2022 -0.21%
Jun 30, 2022 15.78%
Mar 31, 2022 -8.17%
Dec 31, 2021 9.77%
Sep 30, 2021 9.53%
Jun 30, 2021 11.50%